{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:13:42Z","timestamp":1793150022378,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T00:00:00Z","timestamp":1633824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T00:00:00Z","timestamp":1633824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Conicity index, body-shape index, lipid accumulation product (LAP), waist circumference (WC), triglyceride, triglyceride-glucose (TyG) index, hepatic steatosis index (HSI), waist-to-height ratio (WHtR), TyG index-related parameters (TyG-WHtR, TyG-BMI, TyG-WC), body mass index (BMI), visceral adiposity index, triglyceride to high-density lipoprotein cholesterol ratio and body roundness index have been reported as reliable markers of non-alcoholic fatty liver disease (NAFLD). However, there is debate about which of the above obesity and lipid-related indices has the best predictive performance for NAFLD risk.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study included 6870 female and 7411 male subjects, and 15 obesity and lipid-related indices were measured and calculated. NAFLD was diagnosed by abdominal ultrasound. The area under the curve (AUC) of 15 obesity and lipid-related indices were calculated by receiver operating characteristic (ROC) analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among the 15 obesity and lipid-related indices, the TyG index-related parameters had the strongest association with NAFLD. ROC analysis showed that except for ABSI, the other 14 parameters had high predictive value in identifying NAFLD, especially in female and young subjects. Most notably, TyG index-related parameters performed better than other parameters in predicting NAFLD in most populations. In the female population, the AUC of TyG-WC for predicting NAFLD was 0.9045, TyG-BMI was 0.9084, and TyG-WHtR was 0.9071. In the male population, the AUC of TyG-WC was 0.8356, TyG-BMI was 0.8428, and TyG-WHtR was 0.8372. In addition, BMI showed good NAFLD prediction performance in most subgroups (AUC&gt;0.8).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our data suggest that TyG index-related parameters, LAP, HSI, BMI, and WC appear to be good predictors of NAFLD. Of these parameters, TyG index-related parameters showed the best predictive potential.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-021-01561-2","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T21:35:49Z","timestamp":1633901749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":180,"title":["The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease"],"prefix":"10.1186","volume":"20","author":[{"given":"Guotai","family":"Sheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maobin","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9373-928X","authenticated-orcid":false,"given":"Yang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,10]]},"reference":[{"key":"1561_CR1","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62:S47\u201364.","journal-title":"J Hepatol."},{"key":"1561_CR2","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1161\/ATVBAHA.114.305200","volume":"35","author":"MT Long","year":"2015","unstructured":"Long MT, Wang N, Larson MG, Mitchell GF, Palmisano J, Vasan RS, et al. Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study. Arterioscler Thromb Vasc Biol. 2015;35:1284\u201391.","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"1561_CR3","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"75","author":"DH Ipsen","year":"2018","unstructured":"Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci. 2018;75:3313\u201327.","journal-title":"Cell Mol Life Sci."},{"key":"1561_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/liv.13301","volume":"37","author":"P Bedossa","year":"2017","unstructured":"Bedossa P. Pathology of non-alcoholic fatty liver disease. Liver Int. 2017;37:85\u20139.","journal-title":"Liver Int."},{"key":"1561_CR5","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","volume":"62","author":"S McPherson","year":"2015","unstructured":"McPherson S, Hardy T, Henderson E, Burt AD, Day CP, Anstee QM. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. J Hepatol. 2015;62:1148\u201355.","journal-title":"J Hepatol."},{"key":"1561_CR6","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.metabol.2016.01.012","volume":"65","author":"Y Fazel","year":"2016","unstructured":"Fazel Y, Koenig AB, Sayiner M, Goodman ZD, Younossi ZM. Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism. 2016;65:1017\u201325.","journal-title":"Metabolism."},{"key":"1561_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73\u201384.","journal-title":"Hepatology."},{"key":"1561_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"1561_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/jgh.12271","volume":"28","author":"E Hashimoto","year":"2013","unstructured":"Hashimoto E, Taniai M, Tokushige K. Characteristics and diagnosis of NAFLD\/NASH. J Gastroenterol Hepatol. 2013;28:64\u201370.","journal-title":"J Gastroenterol Hepatol."},{"key":"1561_CR10","doi-asserted-by":"crossref","unstructured":"Castera L, Friedrich-Rust M, Loomba R. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2019;156:1264-1281.e4.","DOI":"10.1053\/j.gastro.2018.12.036"},{"key":"1561_CR11","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3748\/wjg.v25.i11.1307","volume":"25","author":"JH Zhou","year":"2019","unstructured":"Zhou JH, Cai JJ, She ZG, Li HL. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. World J Gastroenterol. 2019;25:1307\u201326.","journal-title":"World J Gastroenterol."},{"key":"1561_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.25122\/jml-2018-0031","volume":"11","author":"R Mansour-Ghanaei","year":"2018","unstructured":"Mansour-Ghanaei R, Mansour-Ghanaei F, Naghipour M, Joukar F, Atrkar-Roushan Z, Tabatabaii M, et al. The role of anthropometric indices in the prediction of non-alcoholic fatty liver disease in the PERSIAN Guilan Cohort study (PGCS). J Med Life. 2018;11:194\u2013202.","journal-title":"J Med Life."},{"key":"1561_CR13","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12944-018-0913-3","volume":"17","author":"R Zheng","year":"2018","unstructured":"Zheng R, Du Z, Wang M, Mao Y, Mao W. A longitudinal epidemiological study on the triglyceride and glucose index and the incident nonalcoholic fatty liver disease. Lipids Health Dis. 2018;17:262.","journal-title":"Lipids Health Dis."},{"key":"1561_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/met.2020.0109","volume":"19","author":"ME Khamseh","year":"2021","unstructured":"Khamseh ME, Malek M, Abbasi R, Taheri H, Lahouti M, Alaei-Shahmiri F. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight\/Obesity. Metab Syndr Relat Disord. 2021;19:167\u201373.","journal-title":"Metab Syndr Relat Disord."},{"key":"1561_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12944-019-0986-7","volume":"18","author":"N Fan","year":"2019","unstructured":"Fan N, Peng L, Xia Z, Zhang L, Song Z, Wang Y, et al. Triglycerides to high-density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: a cross-sectional study. Lipids Health Dis. 2019;18:39.","journal-title":"Lipids Health Dis."},{"key":"1561_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243068","volume":"15","author":"Y Zou","year":"2020","unstructured":"Zou Y, Sheng G, Yu M, Xie G. The association between triglycerides and ectopic fat obesity: An inverted U-shaped curve. PLoS One. 2020;15:e0243068.","journal-title":"PLoS One."},{"key":"1561_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12876-021-01824-3","volume":"21","author":"G Sheng","year":"2021","unstructured":"Sheng G, Xie Q, Wang R, Hu C, Zhong M, Zou Y. Waist-to-height ratio and non-alcoholic fatty liver disease in adults. BMC Gastroenterol. 2021;21:239.","journal-title":"BMC Gastroenterol."},{"key":"1561_CR18","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42:503\u20138.","journal-title":"Dig Liver Dis."},{"key":"1561_CR19","doi-asserted-by":"crossref","unstructured":"Dai H, Wang W, Chen R, Chen Z, Lu Y, Yuan H. Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults. Nutr Metab (Lond). 2017;14:49.","DOI":"10.1186\/s12986-017-0206-2"},{"key":"1561_CR20","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.clinre.2019.04.002","volume":"44","author":"T Okamura","year":"2020","unstructured":"Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study. Clin Res Hepatol Gastroenterol. 2020;44:375\u201383.","journal-title":"Clin Res Hepatol Gastroenterol."},{"key":"1561_CR21","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3390\/ijerph18030857","volume":"18","author":"IT Lin","year":"2021","unstructured":"Lin IT, Lee MY, Wang CW, Wu DW, Chen SC. Gender Differences in the Relationships among Metabolic Syndrome and Various Obesity-Related Indices with Nonalcoholic Fatty Liver Disease in a Taiwanese Population. Int J Environ Res Public Health. 2021;18:857.","journal-title":"Int J Environ Res Public Health."},{"key":"1561_CR22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/liv.13970","volume":"39","author":"F Procino","year":"2019","unstructured":"Procino F, Misciagna G, Veronese N, Caruso MG, Chiloiro M, Cisternino AM, et al. Reducing NAFLD-screening time: A comparative study of eight diagnostic methods offering an alternative to ultrasound scans. Liver Int. 2019;39:187\u201396.","journal-title":"Liver Int."},{"key":"1561_CR23","first-page":"6678755","volume":"2021","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Li B, Liu N, Wang P, He J. Evaluation of Different Anthropometric Indicators for Screening for Nonalcoholic Fatty Liver Disease in Elderly Individuals. Int J Endocrinol. 2021;2021:6678755.","journal-title":"Int J Endocrinol."},{"key":"1561_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12944-020-01409-1","volume":"19","author":"Y Li","year":"2020","unstructured":"Li Y, Zheng R, Li J, Feng S, Wang L, Huang Z. Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study. Lipids Health Dis. 2020;19:229.","journal-title":"Lipids Health Dis."},{"key":"1561_CR25","doi-asserted-by":"crossref","unstructured":"Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study. Int J Obes (Lond). 2019;43:139-148.","DOI":"10.1038\/s41366-018-0076-3"},{"key":"1561_CR26","doi-asserted-by":"publisher","unstructured":"Okamura T, et al. Data from: Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study. Dryad, Dataset. 2019. https:\/\/doi.org\/10.5061\/dryad.8q0p192.","DOI":"10.5061\/dryad.8q0p192"},{"key":"1561_CR27","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3350\/cmh.2020.0163","volume":"26","author":"JH Choi","year":"2020","unstructured":"Choi JH, Sohn W, Cho YK. The effect of moderate alcohol drinking in nonalcoholic fatty liver disease. Clin Mol Hepatol. 2020;26:662\u20139.","journal-title":"Clin Mol Hepatol."},{"key":"1561_CR28","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1017\/S0029665113001249","volume":"72","author":"CD Byrne","year":"2013","unstructured":"Byrne CD. Ectopic fat, insulin resistance and non-alcoholic fatty liver disease. Proc Nutr Soc. 2013;72:412\u20139.","journal-title":"Proc Nutr Soc."},{"key":"1561_CR29","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/pedi.12303","volume":"17","author":"NS Mohd Nor","year":"2016","unstructured":"Mohd Nor NS, Lee S, Bacha F, Tfayli H, Arslanian S. Triglyceride glucose index as a surrogate measure of insulin sensitivity in obese adolescents with normoglycemia, prediabetes, and type 2 diabetes mellitus: comparison with the hyperinsulinemic-euglycemic clamp. Pediatr Diabetes. 2016;17:458\u201365.","journal-title":"Pediatr Diabetes."},{"key":"1561_CR30","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Ramos-Zavala MG, Hern\u00e1ndez-Gonz\u00e1lez SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95:3347\u201351.","journal-title":"J Clin Endocrinol Metab."},{"key":"1561_CR31","doi-asserted-by":"publisher","first-page":"4678526","DOI":"10.1155\/2020\/4678526","volume":"2020","author":"A S\u00e1nchez-Garc\u00eda","year":"2020","unstructured":"S\u00e1nchez-Garc\u00eda A, Rodr\u00edguez-Guti\u00e9rrez R, Mancillas-Adame L, Gonz\u00e1lez-Nava V, D\u00edaz Gonz\u00e1lez-Colmenero A, Solis RC, et al. Diagnostic Accuracy of the Triglyceride and Glucose Index for Insulin Resistance: A Systematic Review. Int J Endocrinol. 2020;2020:4678526.","journal-title":"Int J Endocrinol."},{"key":"1561_CR32","doi-asserted-by":"publisher","first-page":"5121574","DOI":"10.1155\/2019\/5121574","volume":"2019","author":"A Kitae","year":"2019","unstructured":"Kitae A, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study. Can J Gastroenterol Hepatol. 2019;2019:5121574.","journal-title":"Can J Gastroenterol Hepatol."},{"key":"1561_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149731","volume":"11","author":"LK Er","year":"2016","unstructured":"Er LK, Wu S, Chou HH, Hsu LA, Teng MS, Sun YC, et al. Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals. PLoS One. 2016;11:e0149731.","journal-title":"PLoS One."},{"key":"1561_CR34","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.jacl.2018.01.005","volume":"12","author":"A Uruska","year":"2018","unstructured":"Uruska A, Zozulinska-Ziolkiewicz D, Niedzwiecki P, Pietrzak M, Wierusz-Wysocka B. TG\/HDL-C ratio and visceral adiposity index may be useful in assessment of insulin resistance in adults with type 1 diabetes in clinical practice. J Clin Lipidol. 2018;12:734\u201340.","journal-title":"J Clin Lipidol."},{"key":"1561_CR35","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1210\/er.2019-00034","volume":"40","author":"MJ Watt","year":"2019","unstructured":"Watt MJ, Miotto PM, De Nardo W, Montgomery MK. The Liver as an Endocrine Organ-Linking NAFLD and Insulin Resistance. Endocr Rev. 2019;40:1367\u201393.","journal-title":"Endocr Rev."},{"key":"1561_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-000904","volume":"8","author":"S Ciardullo","year":"2020","unstructured":"Ciardullo S, Muraca E, Perra S, Bianconi E, Zerbini F, Oltolini A, et al. Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications. BMJ Open Diabetes Res Care. 2020;8:e000904.","journal-title":"BMJ Open Diabetes Res Care."},{"key":"1561_CR37","doi-asserted-by":"crossref","unstructured":"Song E, Kim JA, Roh E, Yu JH, Kim NH, Yoo HJ, et al. Long Working Hours and Risk of Nonalcoholic Fatty Liver Disease: Korea National Health and Nutrition Examination Survey VII. Front Endocrinol (Lausanne). 2021;12:647459.","DOI":"10.3389\/fendo.2021.647459"},{"key":"1561_CR38","doi-asserted-by":"crossref","unstructured":"Mirr M, Skrypnik D, Bogda\u0144ski P, Owecki M. Newly proposed insulin resistance indexes called TyG-NC and TyG-NHtR show efficacy in diagnosing the metabolic syndrome. J Endocrinol Invest. 2021.","DOI":"10.1007\/s40618-021-01608-2"},{"key":"1561_CR39","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.3748\/wjg.v25.i40.6053","volume":"25","author":"G Ferraioli","year":"2019","unstructured":"Ferraioli G, Soares Monteiro LB. Ultrasound-based techniques for the diagnosis of liver steatosis. World J Gastroenterol. 2019;25:6053\u201362.","journal-title":"World J Gastroenterol."}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01561-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-021-01561-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01561-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T21:36:06Z","timestamp":1633901766000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-021-01561-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,10]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1561"],"URL":"https:\/\/doi.org\/10.1186\/s12944-021-01561-2","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,10]]},"assertion":[{"value":"26 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Murakami Memorial Hospital Research Ethics Committee authorized the NAGALA study. Since this study is a post-hoc analysis of the NAGALA study, there is no need to apply for ethical approval again.The entire study process follows the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}